Bhadra Sombuddha, Drgastin Rachel H, Song Howard K, Tibayan Frederick A, Lantz Gurion, Doberne Julie W, Bhamidipati Castigliano M
Division of Cardiothoracic Surgery, Department of Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, MC #L353, Portland, ON 97239, USA.
J Pers Med. 2025 May 21;15(5):211. doi: 10.3390/jpm15050211.
Aortic dissection is a life-threatening condition where emergent surgical repair is the standard of care. However, despite operative intervention, mortality is 10-15% in all patients. Objective markers to distinguish when surgical repair is more beneficial versus being futile are warranted. Currently, no such known measures are widely agreed upon. Since most complications from aortic dissection stem from malperfusion, serum lactate is thought to be a surrogate marker for malperfusion. This scoping review aims to examine the preoperative predictive value of lactate or lactate dehydrogenase (LDH) in assessing postoperative mortality in patients undergoing surgical repair for acute Stanford Type A aortic dissection (ATAAD). PubMed was searched for the following search terms: "Dissection, Ascending Aorta", "Dissection, Thoracic Aorta", or "Aortic Dissection". Prospective and retrospective randomized controlled trials, case reports, and cohort studies were included in the initial search. Studies were first screened for inclusion of preoperative lactate or LDH level with a search of "lac" or "LDH". Included studies consisted of patients aged 18 or older diagnosed with Stanford Type A/Debakey Type I and II aortic dissection with reported preoperative lactate or LDH levels and postoperative mortality treated within 14 days of symptom onset. Preoperative laboratory values were measured from samples collected prior to patient transfer to the operating room or before utilization of ECMO intraoperatively. A comprehensive database search identified a total of 4722 articles. After a rigid screening process, 46 studies fit the inclusion criteria. These papers reported a combined 4696 participants with either preoperative lactate or LDH levels and postoperative mortality. The mean preoperative lactate level was 2.4 mmol/L, whereas the LDH level was 424.9 U/L. Postoperative mortality was 16.51%. Average creatinine, BUN, platelets, INR, PT, PTT, and hemoglobin were all within normal lab analysis limits. Neither lactate nor LDH should be used as a solo predictor of postoperative mortality after ATAAD due to lack of consensus on the cut-off values. Accompanying clinical signs, lab abnormalities, and radiographic findings taken together may be better predictors of prognosis.
主动脉夹层是一种危及生命的疾病,紧急手术修复是其标准治疗方法。然而,尽管进行了手术干预,所有患者的死亡率仍为10% - 15%。因此,需要有客观指标来区分何时手术修复更有益,何时徒劳无功。目前,尚无此类得到广泛认可的已知指标。由于主动脉夹层的大多数并发症源于灌注不良,血清乳酸被认为是灌注不良的替代指标。本综述旨在探讨乳酸或乳酸脱氢酶(LDH)在评估急性斯坦福A型主动脉夹层(ATAAD)手术修复患者术后死亡率方面的术前预测价值。在PubMed数据库中搜索了以下检索词:“升主动脉夹层”、“胸主动脉夹层”或“主动脉夹层”。初步检索纳入前瞻性和回顾性随机对照试验、病例报告及队列研究。首先通过搜索“lac”或“LDH”筛选纳入术前乳酸或LDH水平的研究。纳入研究的患者年龄在18岁及以上,诊断为斯坦福A型/德巴基I型和II型主动脉夹层,报告了术前乳酸或LDH水平以及症状发作后14天内接受治疗的术后死亡率。术前实验室值从患者转入手术室之前或术中使用体外膜肺氧合(ECMO)之前采集的样本中测量。全面的数据库搜索共识别出4722篇文章。经过严格筛选过程,46项研究符合纳入标准。这些论文报告了总共4696名有术前乳酸或LDH水平及术后死亡率的参与者。术前乳酸平均水平为2.4 mmol/L,而LDH水平为424.9 U/L。术后死亡率为16.51%。平均肌酐、尿素氮、血小板、国际标准化比值(INR)、凝血酶原时间(PT)、活化部分凝血活酶时间(PTT)和血红蛋白均在正常实验室分析范围内。由于在临界值上缺乏共识,乳酸和LDH均不应单独用作ATAAD术后死亡率的预测指标。综合临床体征、实验室异常和影像学表现可能是更好的预后预测指标。